Literature DB >> 25090947

Therapy: Hitting the target: delivering IL-10 to treat experimental arthritis.

Katrina Ray.   

Abstract

Entities:  

Year:  2014        PMID： 25090947     DOI： 10.1038/nrrheum.2014.135

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  2 in total

1.  Disease-regulated local IL-10 gene therapy diminishes synovitis and cartilage proteoglycan depletion in experimental arthritis.

Authors:  Eline A Vermeij; Mathijs G A Broeren; Miranda B Bennink; Onno J Arntz; Inger Gjertsson; Peter L E M van Lent; Wim B van den Berg; Marije I Koenders; Fons A J van de Loo
Journal:  Ann Rheum Dis       Date:  2014-07-15       Impact factor: 19.103

2.  Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency.

Authors:  Chris Hughes; Angelica Sette; Michael Seed; Fulvio D'Acquisto; Antonio Manzo; Tonia L Vincent; Ngee Han Lim; Ahuva Nissim
Journal:  Arthritis Res Ther       Date:  2014-07-16       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.